AbbVie reached a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future ...

FAYETTEVILLE, NY, UNITED STATES, January 7, 2026 /EINPresswire.com/ — January is traditionally a peak period for ...

Most U.S. adults have risk factors tied to a little-known condition called CKM syndrome, which connects heart disease, kidney ...

German Chancellor Friedrich Merz said the world should brace for more uncertainty with the return of global power politics, ...

A strategic partnership with CommonSpirit Health aims to increase adherence to evidence-based guidelines (EBGs), improving screening and diagnosis of cardio-kidney-metabolic (CKM) diseases -- The ...

Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients Ingelheim, Germany– 12 January, 2026 – Boehringer Ingelheim today announced a strategic ...

Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

Part of the challenge lies with identifying otherwise healthy individuals — especially women — who lack standard modifiable ...

Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients Ingelheim, Germany- 12 January, 2026 - Boehringer Ingelheim today announced a strategic ...

Scott Drutman Incoming Chief Medical Officer of Enara Bio Boehringer Ingelheim exercises option to license additional Dark ...

Boehringer Ingelheim has unveiled its second kidney-focused collaboration in recent weeks, this time penning a ...